[(2R,3R,4R,5R)-3,4-diacetyloxy-5-[4-cyano-5-(dimethylcarbamoylamino)imidazol-1-yl]oxolan-2-yl]methyl acetate

C18H23N5O8 — CID 22807407

IUPAC[(2R,3R,4R,5R)-3,4-diacetyloxy-5-[4-cyano-5-(dimethylcarbamoylamino)imidazol-1-yl]oxolan-2-yl]methyl acetate
SMILESCC(=O)OC[C@H]1O[C@@H](n2cnc(C#N)c2NC(=O)N(C)C)[C@H](OC(C)=O)[C@@H]1OC(C)=O
InChIInChI=1S/C18H23N5O8/c1-9(24)28-7-13-14(29-10(2)25)15(30-11(3)26)17(31-13)23-8-20-12(6-19)16(23)21-18(27)22(4)5/h8,13-15,17H,7H2,1-5H3,(H,21,27)/t13-,14-,15-,17-/m1/s1
InChIKeyGFVNBNCHWDRYKA-KCYZZUKISA-N
MW437.41 g/mol
LogP0.17
Rot. Bonds6

About [(2R,3R,4R,5R)-3,4-diacetyloxy-5-[4-cyano-5-(dimethylcarbamoylamino)imidazol-1-yl]oxolan-2-yl]methyl acetate

[(2R,3R,4R,5R)-3,4-diacetyloxy-5-[4-cyano-5-(dimethylcarbamoylamino)imidazol-1-yl]oxolan-2-yl]methyl acetate (PubChem CID 22807407) has the molecular formula C18H23N5O8 and a molecular weight of 437.41 g/mol. Its IUPAC name is [(2R,3R,4R,5R)-3,4-diacetyloxy-5-[4-cyano-5-(dimethylcarbamoylamino)imidazol-1-yl]oxolan-2-yl]methyl acetate.

Molecular Properties

Compound Name[(2R,3R,4R,5R)-3,4-diacetyloxy-5-[4-cyano-5-(dimethylcarbamoylamino)imidazol-1-yl]oxolan-2-yl]methyl acetate
PubChem CID22807407
Molecular FormulaC18H23N5O8
Molecular Weight437.41 g/mol
Exact Mass437.15
IUPAC Name[(2R,3R,4R,5R)-3,4-diacetyloxy-5-[4-cyano-5-(dimethylcarbamoylamino)imidazol-1-yl]oxolan-2-yl]methyl acetate
SMILESCC(=O)OC[C@H]1O[C@@H](n2cnc(C#N)c2NC(=O)N(C)C)[C@H](OC(C)=O)[C@@H]1OC(C)=O
InChIInChI=1S/C18H23N5O8/c1-9(24)28-7-13-14(29-10(2)25)15(30-11(3)26)17(31-13)23-8-20-12(6-19)16(23)21-18(27)22(4)5/h8,13-15,17H,7H2,1-5H3,(H,21,27)/t13-,14-,15-,17-/m1/s1
InChIKeyGFVNBNCHWDRYKA-KCYZZUKISA-N
XLogP0.17
TPSA162.08 Ų
H-Bond Donors1
H-Bond Acceptors11
Rotatable Bonds6
Heavy Atoms31
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500437.41
LogP ≤ 50.17
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}

Analyze [(2R,3R,4R,5R)-3,4-diacetyloxy-5-[4-cyano-5-(dimethylcarbamoylamino)imidazol-1-yl]oxolan-2-yl]methyl acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [(2R,3R,4R,5R)-3,4-diacetyloxy-5-[4-cyano-5-(dimethylcarbamoylamino)imidazol-1-yl]oxolan-2-yl]methyl acetate?
The IUPAC name of [(2R,3R,4R,5R)-3,4-diacetyloxy-5-[4-cyano-5-(dimethylcarbamoylamino)imidazol-1-yl]oxolan-2-yl]methyl acetate (CID 22807407) is [(2R,3R,4R,5R)-3,4-diacetyloxy-5-[4-cyano-5-(dimethylcarbamoylamino)imidazol-1-yl]oxolan-2-yl]methyl acetate.
What is the SMILES notation for [(2R,3R,4R,5R)-3,4-diacetyloxy-5-[4-cyano-5-(dimethylcarbamoylamino)imidazol-1-yl]oxolan-2-yl]methyl acetate?
The canonical SMILES for [(2R,3R,4R,5R)-3,4-diacetyloxy-5-[4-cyano-5-(dimethylcarbamoylamino)imidazol-1-yl]oxolan-2-yl]methyl acetate is CC(=O)OC[C@H]1O[C@@H](n2cnc(C#N)c2NC(=O)N(C)C)[C@H](OC(C)=O)[C@@H]1OC(C)=O.
What is the InChIKey of [(2R,3R,4R,5R)-3,4-diacetyloxy-5-[4-cyano-5-(dimethylcarbamoylamino)imidazol-1-yl]oxolan-2-yl]methyl acetate?
The InChIKey is GFVNBNCHWDRYKA-KCYZZUKISA-N. The full InChI is InChI=1S/C18H23N5O8/c1-9(24)28-7-13-14(29-10(2)25)15(30-11(3)26)17(31-13)23-8-20-12(6-19)16(23)21-18(27)22(4)5/h8,13-15,17H,7H2,1-5H3,(H,21,27)/t13-,14-,15-,17-/m1/s1.
What are the key properties of [(2R,3R,4R,5R)-3,4-diacetyloxy-5-[4-cyano-5-(dimethylcarbamoylamino)imidazol-1-yl]oxolan-2-yl]methyl acetate?
[(2R,3R,4R,5R)-3,4-diacetyloxy-5-[4-cyano-5-(dimethylcarbamoylamino)imidazol-1-yl]oxolan-2-yl]methyl acetate has a molecular weight of 437.41 g/mol, XLogP of 0.17, 6 rotatable bonds, 1 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for [(2R,3R,4R,5R)-3,4-diacetyloxy-5-[4-cyano-5-(dimethylcarbamoylamino)imidazol-1-yl]oxolan-2-yl]methyl acetate is sourced from PubChem (CID 22807407), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).